Volume-based assessment by F-18-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hyun, Seung Hyup | - |
dc.contributor.author | Ahn, Hee Kyung | - |
dc.contributor.author | Kim, Hojoong | - |
dc.contributor.author | Ahn, Myung-Ju | - |
dc.contributor.author | Park, Keunchil | - |
dc.contributor.author | Ahn, Yong Chan | - |
dc.contributor.author | Kim, Jhingook | - |
dc.contributor.author | Shim, Young Mog | - |
dc.contributor.author | Choi, Joon Young | - |
dc.date.available | 2020-02-28T18:43:24Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2014-01 | - |
dc.identifier.issn | 1619-7070 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/12914 | - |
dc.description.abstract | We evaluated the prognostic impact of volume-based assessment by F-18-FDG PET/CT in patients with stage III non-small-cell lung cancer (NSCLC). We reviewed 194 consecutive patients with stage IIIA NSCLC treated with surgical resection (surgical group) and 115 patients treated with nonsurgical therapy (nonsurgical group: 50 stage IIIA, 65 stage IIIB). Metabolic tumour volume (MTV), total lesion glycolysis (TLG), and maximum standardized uptake value (SUVmax) of primary tumours were measured using pretreatment F-18-FDG PET/CT. Overall survival was assessed using the Kaplan-Meier method. The prognostic significance of PET parameters and other clinical variables was assessed using Cox proportional hazards regression analyses. To evaluate and compare the predictive performance of PET parameters, time-dependent receiver operating characteristic (ROC) curve analysis was used. In the Cox proportional hazards models, MTV (HR = 1.27 for a doubling of MTV, P = 0.008) and TLG (HR = 1.22 for a doubling of TLG, P = 0.035) were significantly associated with an increased risk of death after adjusting for age, gender, histological cell type, T stage, N stage, and treatment variables in the surgical group. SUVmax was not a significant prognostic factor in either the surgical or nonsurgical group. In the time-dependent ROC curve analysis, volume-based PET parameters predicted survival better than SUVmax. The volume-based PET parameters (MTV and TLG) are significant prognostic factors for survival independent of tumour stage and better prognostic imaging biomarkers than SUVmax in patients with stage IIIA NSCLC after surgical resection. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.relation.isPartOf | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - |
dc.subject | POSITRON-EMISSION-TOMOGRAPHY | - |
dc.subject | PROGNOSTIC VALUE | - |
dc.subject | MULTICENTER TRIALS | - |
dc.subject | STANDARD UPTAKE | - |
dc.subject | ROI DEFINITION | - |
dc.subject | UPTAKE VALUES | - |
dc.subject | QUANTIFICATION | - |
dc.subject | PARAMETERS | - |
dc.subject | RESOLUTION | - |
dc.subject | GUIDELINE | - |
dc.title | Volume-based assessment by F-18-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000327895200008 | - |
dc.identifier.doi | 10.1007/s00259-013-2530-8 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, v.41, no.1, pp.50 - 58 | - |
dc.identifier.scopusid | 2-s2.0-84890802795 | - |
dc.citation.endPage | 58 | - |
dc.citation.startPage | 50 | - |
dc.citation.title | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - |
dc.citation.volume | 41 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Ahn, Hee Kyung | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Metabolic tumour volume | - |
dc.subject.keywordAuthor | Total lesion glycolysis | - |
dc.subject.keywordAuthor | Standardized uptake value | - |
dc.subject.keywordAuthor | Non-small-cell lung cancer | - |
dc.subject.keywordAuthor | F-18-FDG PET/CT | - |
dc.subject.keywordPlus | POSITRON-EMISSION-TOMOGRAPHY | - |
dc.subject.keywordPlus | PROGNOSTIC VALUE | - |
dc.subject.keywordPlus | MULTICENTER TRIALS | - |
dc.subject.keywordPlus | STANDARD UPTAKE | - |
dc.subject.keywordPlus | ROI DEFINITION | - |
dc.subject.keywordPlus | UPTAKE VALUES | - |
dc.subject.keywordPlus | QUANTIFICATION | - |
dc.subject.keywordPlus | PARAMETERS | - |
dc.subject.keywordPlus | RESOLUTION | - |
dc.subject.keywordPlus | GUIDELINE | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.